IGF1 and pancreatic neoplasm: Autocrine IGF1 signalling has recently been identified as an essential survival mechanism for quiescent cancer cells derived from murine pancreatic tumours, allowing for growth and apoptosis resistance in spite of mutations in KRAS or MYC.